Web Results


Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. The company??s da Vinci surgical System translates a surgeon??s natural hand movements, which are performed on instrument controls at a console into corresponding micro- movements of ...


May 19, 2016 ... It develops and manufactures da Vinci surgical systems and related instruments and accessories to enable minimally invasive surgeries with better outcomes and shorter hospital stays. Intuitive Surgical is part of the S&P 500 and the NASDAQ 100. The company's flagship surgical system, the da Vinci ...


Intuitive Surgical is an SRI International spin-off venture company.


Latest Intuitive Surgical Inc (ISRG:NSQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.


Santa Barbara, CA, June 13, 2016 – InTouch Health, the leading specialty telehealth network and managed service provider, today announced that it has entered into a strategic collaboration with Intuitive Surgical, Inc. (Nasdaq: ISRG), which includes an investment by Intuitive Surgical in the company and a collaboration ...


Jan 12, 2018 ... $TRXC people think is a Joke I block Bears Left and Right. the Only competition on a World Market is $ISRG with a Stock Value $433.25. 9. 1. shortvolumesJan 18th, 10:31 am. The short sell volume percent for $ISRG on 2018-01-17 is 53%. shortvolumes.com/?t=ISRG $TFX 72% $SYK 59% $MDT 27% ...


ETFs with Intuitive Surgical Inc (ISRG) Exposure. The following ETFs maintain exposure to Intuitive Surgical Inc (ISRG). ETF holdings data are updated once a day, and are subject to change. To see a complete breakdown of any of the ETFs included in the table below, including sector, market cap, and country allocations,  ...


View the latest ISRG stock price with Barron's. Including historical share prices, analysis, earnings, cash flow and market valuation for Intuitive Surgical Inc.


Oct 20, 2017 ... Celgene (CELG) won't start phase 3 trial for Crohn's disease drug, while Intuitive Surgical (ISRG) and Skechers (SKX) reports on earnings.